Investor Relations We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology. Email Alerts Investors: Overview Press Releases Events and Presentations Financials & Filings Stock Information Investor FAQs Contact Us Events Presentations Cantor Fitzgerald Virtual Global Healthcare Conference Monday, September 27, 2021 -Thursday, September 30, 2021 1:20pm EDT Listen to the Webcast